The Opioids market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Opioids market size is estimated to be worth US$ 15210 million in 2021 and is forecast to a readjusted size of USD 18070 million by 2028 with a CAGR of 2.5% during review period. Pain Relief accounting for % of the Opioids global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Oxycodone segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Opioids include Teva, Purdue Pharma, Mallinckrodt, Amneal Pharma, and Collegium, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market Segmentation
Opioids market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Oxycodone
- Hydromorphone
- Codeine
- Fentanyl
- Other
Market segment by Application can be divided into
- Pain Relief
- Anesthesia
- Cough Suppression
- Diarrhea Suppression
- Deaddiction
- Others
The key market players for global Opioids market are listed below:
- Teva
- Purdue Pharma
- Mallinckrodt
- Amneal Pharma
- Collegium
- J&J
- Endo
- Pfizer
- INSYS
- Mylan
- Hikma
- Egalet
Market segment by region, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Opioids product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Opioids, with price, sales, revenue and global market share of Opioids from 2019 to 2022.
Chapter 3, the Opioids competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioids breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Opioids market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Opioids.
Chapter 13, 14, and 15, to describe Opioids sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Global Opioids Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
Table of Contents
1 Market Overview
1.1 Opioids Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Opioids Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Opioids Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Cough Suppression
1.3.5 Diarrhea Suppression
1.3.6 Deaddiction
1.3.7 Others
1.4 Global Opioids Market Size & Forecast
1.4.1 Global Opioids Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Opioids Sales in Volume (2017-2028)
1.4.3 Global Opioids Price (2017-2028)
1.5 Global Opioids Production Capacity Analysis
1.5.1 Global Opioids Total Production Capacity (2017-2028)
1.5.2 Global Opioids Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Opioids Market Drivers
1.6.2 Opioids Market Restraints
1.6.3 Opioids Trends Analysis
2 Manufacturers Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Opioids Product and Services
2.1.4 Teva Opioids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Purdue Pharma
2.2.1 Purdue Pharma Details
2.2.2 Purdue Pharma Major Business
2.2.3 Purdue Pharma Opioids Product and Services
2.2.4 Purdue Pharma Opioids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Mallinckrodt
2.3.1 Mallinckrodt Details
2.3.2 Mallinckrodt Major Business
2.3.3 Mallinckrodt Opioids Product and Services
2.3.4 Mallinckrodt Opioids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Amneal Pharma
2.4.1 Amneal Pharma Details
2.4.2 Amneal Pharma Major Business
2.4.3 Amneal Pharma Opioids Product and Services
2.4.4 Amneal Pharma Opioids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Collegium
2.5.1 Collegium Details
2.5.2 Collegium Major Business
2.5.3 Collegium Opioids Product and Services
2.5.4 Collegium Opioids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 J&J
2.6.1 J&J Details
2.6.2 J&J Major Business
2.6.3 J&J Opioids Product and Services
2.6.4 J&J Opioids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Endo
2.7.1 Endo Details
2.7.2 Endo Major Business
2.7.3 Endo Opioids Product and Services
2.7.4 Endo Opioids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Opioids Product and Services
2.8.4 Pfizer Opioids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 INSYS
2.9.1 INSYS Details
2.9.2 INSYS Major Business
2.9.3 INSYS Opioids Product and Services
2.9.4 INSYS Opioids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Mylan
2.10.1 Mylan Details
2.10.2 Mylan Major Business
2.10.3 Mylan Opioids Product and Services
2.10.4 Mylan Opioids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Hikma
2.11.1 Hikma Details
2.11.2 Hikma Major Business
2.11.3 Hikma Opioids Product and Services
2.11.4 Hikma Opioids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Egalet
2.12.1 Egalet Details
2.12.2 Egalet Major Business
2.12.3 Egalet Opioids Product and Services
2.12.4 Egalet Opioids Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Opioids Breakdown Data by Manufacturer
3.1 Global Opioids Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Opioids Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Opioids
3.4 Market Concentration Rate
3.4.1 Top 3 Opioids Manufacturer Market Share in 2021
3.4.2 Top 6 Opioids Manufacturer Market Share in 2021
3.5 Global Opioids Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Opioids Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Opioids Market Size by Region
4.1.1 Global Opioids Sales in Volume by Region (2017-2028)
4.1.2 Global Opioids Revenue by Region (2017-2028)
4.2 North America Opioids Revenue (2017-2028)
4.3 Europe Opioids Revenue (2017-2028)
4.4 Asia-Pacific Opioids Revenue (2017-2028)
4.5 South America Opioids Revenue (2017-2028)
4.6 Middle East and Africa Opioids Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Opioids Sales in Volume by Type (2017-2028)
5.2 Global Opioids Revenue by Type (2017-2028)
5.3 Global Opioids Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Opioids Sales in Volume by Application (2017-2028)
6.2 Global Opioids Revenue by Application (2017-2028)
6.3 Global Opioids Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Opioids Sales by Type (2017-2028)
7.2 North America Opioids Sales by Application (2017-2028)
7.3 North America Opioids Market Size by Country
7.3.1 North America Opioids Sales in Volume by Country (2017-2028)
7.3.2 North America Opioids Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Opioids Sales by Type (2017-2028)
8.2 Europe Opioids Sales by Application (2017-2028)
8.3 Europe Opioids Market Size by Country
8.3.1 Europe Opioids Sales in Volume by Country (2017-2028)
8.3.2 Europe Opioids Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Opioids Sales by Type (2017-2028)
9.2 Asia-Pacific Opioids Sales by Application (2017-2028)
9.3 Asia-Pacific Opioids Market Size by Region
9.3.1 Asia-Pacific Opioids Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Opioids Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Opioids Sales by Type (2017-2028)
10.2 South America Opioids Sales by Application (2017-2028)
10.3 South America Opioids Market Size by Country
10.3.1 South America Opioids Sales in Volume by Country (2017-2028)
10.3.2 South America Opioids Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Opioids Sales by Type (2017-2028)
11.2 Middle East & Africa Opioids Sales by Application (2017-2028)
11.3 Middle East & Africa Opioids Market Size by Country
11.3.1 Middle East & Africa Opioids Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Opioids Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Opioids and Key Manufacturers
12.2 Manufacturing Costs Percentage of Opioids
12.3 Opioids Production Process
12.4 Opioids Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Opioids Typical Distributors
13.3 Opioids Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Opioids Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Opioids Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Teva Basic Information, Manufacturing Base and Competitors
Table 4. Teva Major Business
Table 5. Teva Opioids Product and Services
Table 6. Teva Opioids Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 8. Purdue Pharma Major Business
Table 9. Purdue Pharma Opioids Product and Services
Table 10. Purdue Pharma Opioids Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 12. Mallinckrodt Major Business
Table 13. Mallinckrodt Opioids Product and Services
Table 14. Mallinckrodt Opioids Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Amneal Pharma Basic Information, Manufacturing Base and Competitors
Table 16. Amneal Pharma Major Business
Table 17. Amneal Pharma Opioids Product and Services
Table 18. Amneal Pharma Opioids Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Collegium Basic Information, Manufacturing Base and Competitors
Table 20. Collegium Major Business
Table 21. Collegium Opioids Product and Services
Table 22. Collegium Opioids Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. J&J Basic Information, Manufacturing Base and Competitors
Table 24. J&J Major Business
Table 25. J&J Opioids Product and Services
Table 26. J&J Opioids Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Endo Basic Information, Manufacturing Base and Competitors
Table 28. Endo Major Business
Table 29. Endo Opioids Product and Services
Table 30. Endo Opioids Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Pfizer Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer Major Business
Table 33. Pfizer Opioids Product and Services
Table 34. Pfizer Opioids Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. INSYS Basic Information, Manufacturing Base and Competitors
Table 36. INSYS Major Business
Table 37. INSYS Opioids Product and Services
Table 38. INSYS Opioids Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Mylan Basic Information, Manufacturing Base and Competitors
Table 40. Mylan Major Business
Table 41. Mylan Opioids Product and Services
Table 42. Mylan Opioids Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Hikma Basic Information, Manufacturing Base and Competitors
Table 44. Hikma Major Business
Table 45. Hikma Opioids Product and Services
Table 46. Hikma Opioids Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Egalet Basic Information, Manufacturing Base and Competitors
Table 48. Egalet Major Business
Table 49. Egalet Opioids Product and Services
Table 50. Egalet Opioids Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Global Opioids Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 52. Global Opioids Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 53. Market Position of Manufacturers in Opioids, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 54. Global Opioids Production Capacity by Company, (MT): 2020 VS 2021
Table 55. Head Office and Opioids Production Site of Key Manufacturer
Table 56. Opioids New Entrant and Capacity Expansion Plans
Table 57. Opioids Mergers & Acquisitions in the Past Five Years
Table 58. Global Opioids Sales by Region (2017-2022) & (MT)
Table 59. Global Opioids Sales by Region (2023-2028) & (MT)
Table 60. Global Opioids Revenue by Region (2017-2022) & (USD Million)
Table 61. Global Opioids Revenue by Region (2023-2028) & (USD Million)
Table 62. Global Opioids Sales by Type (2017-2022) & (MT)
Table 63. Global Opioids Sales by Type (2023-2028) & (MT)
Table 64. Global Opioids Revenue by Type (2017-2022) & (USD Million)
Table 65. Global Opioids Revenue by Type (2023-2028) & (USD Million)
Table 66. Global Opioids Price by Type (2017-2022) & (USD/Kg)
Table 67. Global Opioids Price by Type (2023-2028) & (USD/Kg)
Table 68. Global Opioids Sales by Application (2017-2022) & (MT)
Table 69. Global Opioids Sales by Application (2023-2028) & (MT)
Table 70. Global Opioids Revenue by Application (2017-2022) & (USD Million)
Table 71. Global Opioids Revenue by Application (2023-2028) & (USD Million)
Table 72. Global Opioids Price by Application (2017-2022) & (USD/Kg)
Table 73. Global Opioids Price by Application (2023-2028) & (USD/Kg)
Table 74. North America Opioids Sales by Country (2017-2022) & (MT)
Table 75. North America Opioids Sales by Country (2023-2028) & (MT)
Table 76. North America Opioids Revenue by Country (2017-2022) & (USD Million)
Table 77. North America Opioids Revenue by Country (2023-2028) & (USD Million)
Table 78. North America Opioids Sales by Type (2017-2022) & (MT)
Table 79. North America Opioids Sales by Type (2023-2028) & (MT)
Table 80. North America Opioids Sales by Application (2017-2022) & (MT)
Table 81. North America Opioids Sales by Application (2023-2028) & (MT)
Table 82. Europe Opioids Sales by Country (2017-2022) & (MT)
Table 83. Europe Opioids Sales by Country (2023-2028) & (MT)
Table 84. Europe Opioids Revenue by Country (2017-2022) & (USD Million)
Table 85. Europe Opioids Revenue by Country (2023-2028) & (USD Million)
Table 86. Europe Opioids Sales by Type (2017-2022) & (MT)
Table 87. Europe Opioids Sales by Type (2023-2028) & (MT)
Table 88. Europe Opioids Sales by Application (2017-2022) & (MT)
Table 89. Europe Opioids Sales by Application (2023-2028) & (MT)
Table 90. Asia-Pacific Opioids Sales by Region (2017-2022) & (MT)
Table 91. Asia-Pacific Opioids Sales by Region (2023-2028) & (MT)
Table 92. Asia-Pacific Opioids Revenue by Region (2017-2022) & (USD Million)
Table 93. Asia-Pacific Opioids Revenue by Region (2023-2028) & (USD Million)
Table 94. Asia-Pacific Opioids Sales by Type (2017-2022) & (MT)
Table 95. Asia-Pacific Opioids Sales by Type (2023-2028) & (MT)
Table 96. Asia-Pacific Opioids Sales by Application (2017-2022) & (MT)
Table 97. Asia-Pacific Opioids Sales by Application (2023-2028) & (MT)
Table 98. South America Opioids Sales by Country (2017-2022) & (MT)
Table 99. South America Opioids Sales by Country (2023-2028) & (MT)
Table 100. South America Opioids Revenue by Country (2017-2022) & (USD Million)
Table 101. South America Opioids Revenue by Country (2023-2028) & (USD Million)
Table 102. South America Opioids Sales by Type (2017-2022) & (MT)
Table 103. South America Opioids Sales by Type (2023-2028) & (MT)
Table 104. South America Opioids Sales by Application (2017-2022) & (MT)
Table 105. South America Opioids Sales by Application (2023-2028) & (MT)
Table 106. Middle East & Africa Opioids Sales by Region (2017-2022) & (MT)
Table 107. Middle East & Africa Opioids Sales by Region (2023-2028) & (MT)
Table 108. Middle East & Africa Opioids Revenue by Region (2017-2022) & (USD Million)
Table 109. Middle East & Africa Opioids Revenue by Region (2023-2028) & (USD Million)
Table 110. Middle East & Africa Opioids Sales by Type (2017-2022) & (MT)
Table 111. Middle East & Africa Opioids Sales by Type (2023-2028) & (MT)
Table 112. Middle East & Africa Opioids Sales by Application (2017-2022) & (MT)
Table 113. Middle East & Africa Opioids Sales by Application (2023-2028) & (MT)
Table 114. Opioids Raw Material
Table 115. Key Manufacturers of Opioids Raw Materials
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Opioids Typical Distributors
Table 119. Opioids Typical Customers
List of Figures
Figure 1. Opioids Picture
Figure 2. Global Opioids Revenue Market Share by Type in 2021
Figure 3. Oxycodone
Figure 4. Hydromorphone
Figure 5. Codeine
Figure 6. Fentanyl
Figure 7. Other
Figure 8. Global Opioids Revenue Market Share by Application in 2021
Figure 9. Pain Relief
Figure 10. Anesthesia
Figure 11. Cough Suppression
Figure 12. Diarrhea Suppression
Figure 13. Deaddiction
Figure 14. Others
Figure 15. Global Opioids Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 16. Global Opioids Revenue and Forecast (2017-2028) & (USD Million)
Figure 17. Global Opioids Sales (2017-2028) & (MT)
Figure 18. Global Opioids Price (2017-2028) & (USD/Kg)
Figure 19. Global Opioids Production Capacity (2017-2028) & (MT)
Figure 20. Global Opioids Production Capacity by Geographic Region: 2022 VS 2028
Figure 21. Opioids Market Drivers
Figure 22. Opioids Market Restraints
Figure 23. Opioids Market Trends
Figure 24. Global Opioids Sales Market Share by Manufacturer in 2021
Figure 25. Global Opioids Revenue Market Share by Manufacturer in 2021
Figure 26. Opioids Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 27. Top 3 Opioids Manufacturer (Revenue) Market Share in 2021
Figure 28. Top 6 Opioids Manufacturer (Revenue) Market Share in 2021
Figure 29. Global Opioids Sales Market Share by Region (2017-2028)
Figure 30. Global Opioids Revenue Market Share by Region (2017-2028)
Figure 31. North America Opioids Revenue (2017-2028) & (USD Million)
Figure 32. Europe Opioids Revenue (2017-2028) & (USD Million)
Figure 33. Asia-Pacific Opioids Revenue (2017-2028) & (USD Million)
Figure 34. South America Opioids Revenue (2017-2028) & (USD Million)
Figure 35. Middle East & Africa Opioids Revenue (2017-2028) & (USD Million)
Figure 36. Global Opioids Sales Market Share by Type (2017-2028)
Figure 37. Global Opioids Revenue Market Share by Type (2017-2028)
Figure 38. Global Opioids Price by Type (2017-2028) & (USD/Kg)
Figure 39. Global Opioids Sales Market Share by Application (2017-2028)
Figure 40. Global Opioids Revenue Market Share by Application (2017-2028)
Figure 41. Global Opioids Price by Application (2017-2028) & (USD/Kg)
Figure 42. North America Opioids Sales Market Share by Type (2017-2028)
Figure 43. North America Opioids Sales Market Share by Application (2017-2028)
Figure 44. North America Opioids Sales Market Share by Country (2017-2028)
Figure 45. North America Opioids Revenue Market Share by Country (2017-2028)
Figure 46. United States Opioids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Opioids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Opioids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Opioids Sales Market Share by Type (2017-2028)
Figure 50. Europe Opioids Sales Market Share by Application (2017-2028)
Figure 51. Europe Opioids Sales Market Share by Country (2017-2028)
Figure 52. Europe Opioids Revenue Market Share by Country (2017-2028)
Figure 53. Germany Opioids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Opioids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Opioids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Opioids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Opioids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Opioids Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Opioids Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Opioids Sales Market Share by Region (2017-2028)
Figure 61. Asia-Pacific Opioids Revenue Market Share by Region (2017-2028)
Figure 62. China Opioids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Opioids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Korea Opioids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Opioids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Opioids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Opioids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Opioids Sales Market Share by Type (2017-2028)
Figure 69. South America Opioids Sales Market Share by Application (2017-2028)
Figure 70. South America Opioids Sales Market Share by Country (2017-2028)
Figure 71. South America Opioids Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Opioids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Opioids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East & Africa Opioids Sales Market Share by Type (2017-2028)
Figure 75. Middle East & Africa Opioids Sales Market Share by Application (2017-2028)
Figure 76. Middle East & Africa Opioids Sales Market Share by Region (2017-2028)
Figure 77. Middle East & Africa Opioids Revenue Market Share by Region (2017-2028)
Figure 78. Turkey Opioids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Egypt Opioids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Opioids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. South Africa Opioids Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Manufacturing Cost Structure Analysis of Opioids in 2021
Figure 83. Manufacturing Process Analysis of Opioids
Figure 84. Opioids Industrial Chain
Figure 85. Sales Channel: Direct Channel vs Indirect Channel
Figure 86. Methodology
Figure 87. Research Process and Data Source
Global Pain Management Drugs Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 93
Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.
This report is mainly about The drugs for pain management.
The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030.
The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......
Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 131
According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period.
The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......
Global Opioids Drug Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 115
According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period.
The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......
Global Methadone Hydrochloride Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 90
According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period.
The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......
Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 02-Jan-2024 Price: US 3380 Onwards Pages: 112
Market Overview of Global Opioids Drugs market:
According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......
Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 111
According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period.
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......
Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 87
According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period.
Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence.
Market Competition is not intense, as t......
Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 131
According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period.
Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.
This report is mainly about the drugs for pain management.
The leading manufacturers in the industry are GSK, Pfizer and Grune......
Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028
Published: 28-Dec-2023 Price: US 2680 Onwards Pages: 167
The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica).
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
